Literature DB >> 6140459

Antibodies to melanocytes in vitiligo.

C Betterle, R Mirakian, D Doniach, G F Bottazzo, W Riley, N K Maclaren.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6140459     DOI： 10.1016/s0140-6736(84)90084-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Authors:  P Agretti; G De Marco; D Sansone; C Betterle; G Coco; A Dimida; E Ferrarini; A Pinchera; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

2.  A human autoantibody to peroxisomes.

Authors:  R Holm; P I Gaarder; L Helgeland; E I Falkenhaug
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

3.  Fatal toxic epidermal necrolysis in autoimmune polyglandular syndrome type I.

Authors:  A Porzionato; S Zancaner; C Betterle; S D Ferrara
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

4.  Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions.

Authors:  C Betterle; A Caretto; M Zeviani; B Pedini; C Salviati
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Identification of tyrosinase inhibitors from traditional Chinese medicines for the management of hyperpigmentation.

Authors:  Hsin-Chieh Tang; Yu-Chian Chen
Journal:  Springerplus       Date:  2015-04-17

Review 6.  Organ-specific autoimmunity: a 1986 overview.

Authors:  G F Bottazzo; I Todd; R Mirakian; A Belfiore; R Pujol-Borrell
Journal:  Immunol Rev       Date:  1986-12       Impact factor: 12.988
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.